Income Statement
ARDENT HEALTH, INC.
ARDT
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY |
|---|---|---|
|
Revenue
|
6,324.34 | 5,966.07 |
|
Cost of Revenue
|
- | - |
|
Gross Profit
|
6,324.34 | 5,966.07 |
|
Operating Expenses
|
0.00 | 0.00 |
|
Research & Development
|
- | - |
|
Selling, General & Administrative
|
2,657.70 | 2,534.76 |
|
Other Operating Expenses
|
- | - |
|
Operating Income
|
6,324.34 | 5,966.07 |
|
Non-Operating Income
|
6,023.34 | 5,603.01 |
|
Interest Income
|
- | - |
|
Interest Expense
|
55.20 | 65.58 |
|
Other Non-Op Income / Expense
|
- | - |
|
Income Before Tax
|
301.00 | 363.06 |
|
Income Tax Expense
|
165.19 | 152.72 |
|
Non-Controlling Interest
|
94.32 | 89.37 |
|
Net Income
|
135.81 | 210.34 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY |
|---|---|---|
|
Depreciation & Amortization
|
- | - |
|
EBITDA
|
6,480.04 | 6,112.37 |
|
Earnings Per Share (Basic)
|
0.96 | 1.59 |
|
Diluted EPS
|
0.96 | 1.58 |
|
Weighted Average Shares
|
140.76 | 132.44 |
|
Diluted Weighted Avg Shares
|
141.45 | 132.74 |
|
Comprehensive Income
|
122.46 | 201.52 |